PGNY
Progyny, Inc. NASDAQ$18.98
Mkt Cap $1.6B
52w Low $16.10
22.8% of range
52w High $28.75
50d MA $18.00
200d MA $21.84
P/E (TTM)
27.4x
EV/EBITDA
20.9x
P/B
3.1x
Debt/Equity
0.1x
ROE
2.4%
P/FCF
11.4x
RSI (14)
—
ATR (14)
—
Beta
0.99
50d MA
$18.00
200d MA
$21.84
Avg Volume
1.5M
About
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits soluti…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | AMC | 0.15 | 0.15 | +2.0% | 22.25 | -10.7% | -20.5% | -20.9% | -21.3% | -20.0% | -20.8% | — |
| Nov 6, 2025 | AMC | 0.39 | 0.45 | +15.4% | 18.01 | +14.8% | +24.2% | +31.1% | +32.2% | +33.6% | +35.6% | — |
| Aug 7, 2025 | AMC | 0.44 | 0.48 | +9.1% | 23.06 | +13.7% | -0.9% | -5.7% | -5.6% | +0.0% | -2.2% | — |
| May 8, 2025 | AMC | 0.45 | 0.48 | +6.7% | 23.37 | -2.6% | -9.3% | -5.9% | -7.2% | -6.5% | -6.1% | — |
| Feb 27, 2025 | AMC | 0.37 | 0.42 | +13.5% | 22.88 | +16.0% | -1.5% | -3.8% | -5.8% | -5.2% | -8.0% | — |
| Nov 12, 2024 | AMC | 0.37 | 0.40 | +8.1% | 17.18 | -13.3% | -19.1% | -18.6% | -19.8% | -19.1% | -20.4% | — |
| Aug 6, 2024 | AMC | 0.36 | 0.43 | +19.4% | 25.74 | -18.4% | -19.0% | -18.6% | -16.0% | -18.3% | -16.1% | — |
| May 9, 2024 | AMC | 0.14 | 0.39 | +178.6% | 32.50 | -26.5% | -15.3% | -15.7% | -15.4% | -17.6% | -15.2% | — |
| Feb 27, 2024 | AMC | 0.11 | 0.32 | +190.9% | 40.79 | -11.3% | -15.1% | -10.5% | -11.7% | -13.0% | -15.4% | — |
| Nov 7, 2023 | AMC | 0.12 | 0.16 | +33.3% | 32.00 | +0.0% | -7.8% | -7.5% | -5.7% | -4.8% | -0.5% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20 | Barclays | Maintains | Overweight → Overweight | — | $18.18 | $18.17 | -0.1% | -0.3% | -0.9% | -0.7% | -2.4% | -2.1% |
| Mar 11 | Canaccord Genuity | Maintains | Hold → Hold | — | $17.91 | $17.65 | -1.5% | -2.2% | -2.3% | -2.3% | -2.7% | +0.8% |
| Mar 5 | BTIG | Maintains | Buy → Buy | — | $17.79 | $17.67 | -0.7% | -1.0% | +2.9% | +2.6% | +0.7% | -1.6% |
| Mar 2 | Truist | Maintains | Buy → Buy | — | $17.69 | $17.27 | -2.4% | -0.5% | -1.0% | +0.6% | -0.4% | +3.5% |
| Mar 2 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $17.69 | $17.27 | -2.4% | -0.5% | -1.0% | +0.6% | -0.4% | +3.5% |
| Jan 20 | Citizens | Upgrade | Market Perform → Market Outperform | — | $24.52 | $25.05 | +2.2% | +3.5% | +3.8% | +2.0% | +2.9% | +1.3% |
| Jan 8 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $26.80 | $27.51 | +2.6% | +2.4% | +0.7% | +6.0% | -5.8% | -2.5% |
| Nov 17 | Canaccord Genuity | Maintains | Hold → Hold | — | $24.55 | $25.50 | +3.9% | +9.2% | +5.3% | +3.5% | +1.1% | +5.3% |
| Nov 12 | KeyBanc Capital Markets | Upgrade | Sector Weight → Overweight | — | $23.81 | $24.32 | +2.1% | +1.1% | +2.6% | +3.1% | +12.6% | +8.6% |
| Nov 11 | JP Morgan | Maintains | Neutral → Neutral | — | $23.62 | $23.79 | +0.7% | +0.8% | +1.9% | +3.4% | +3.9% | +13.5% |
Recent Filings
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
Progyny faces shareholder litigation settlement that could provide legal closure and reduce future liability exposure, though settlement terms remain undisclosed pending court approval.
Mar 13
8-K · 7.01
! Medium
Progyny, Inc. -- 8-K 7.01: Regulation FD Disclosure
Progyny disclosed earnings results and supplemental presentation materials via 8-K filing, providing investors with detailed financial performance information and forward-looking guidance on its investor relations website.
Feb 26
Data updated apr 26, 2026 7:29pm
· Source: massive.com